Is TGF-β1 the key to suppression of human asthma?
Author:
- Atsuhito NakaoANAtsuhito Nakao
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (3) , 115-118
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 15 references indexed in Scilit:
- Blockade of Transforming Growth Factor β/Smad Signaling in T Cells by Overexpression of Smad7 Enhances Antigen-Induced Airway Inflammation and Airway ReactivityJournal of Experimental Medicine, 2000
- Epithelial damage and responseClinical & Experimental Allergy, 2000
- CD4+ T helper cells engineered to produce latent TGF-β1 reverse allergen-induced airway hyperreactivity and inflammationJournal of Clinical Investigation, 2000
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory responseNature Cell Biology, 1999
- Transforming Growth Factor-β Secreted from CD4+ T Cells Ameliorates Antigen-Induced Eosinophilic Inflammation: A Novel High-Dose Tolerance in the TracheaAmerican Journal of Respiratory Cell and Molecular Biology, 1999
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Inflammation in asthma: The cornerstone of the disease and target of therapyJournal of Allergy and Clinical Immunology, 1998
- Transforming Growth Factor- β 1 in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Defence against allergic sensitization in the healthy lung: the role of inhalation toleranceClinical & Experimental Allergy, 1989